Context Therapeutics Inc.
(CNTX)
undefined
undefined%
At close: undefined
1.33
-3.97%
After-hours Dec 13, 2024, 07:27 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -23.96M | -14.84M | -10.46M | 6.64M | -6.38M |
| Depreciation & Amortization | 12.04K | 9.27K | - | - | - |
| Stock-Based Compensation | 1.08M | 976.44K | 511.08K | 219.25K | 775.25K |
| Other Working Capital | 329.03K | 510.37K | -1.36M | 762.03K | 56.38K |
| Other Non-Cash Items | 51.97K | 578.52K | 3.37M | -9.22M | 2.21M |
| Deferred Income Tax | - | - | - | - | - |
| Change in Working Capital | 1.78M | -277.52K | -2.22M | 1.32M | 561.79K |
| Operating Cash Flow | -21.05M | -13.55M | -8.80M | -1.03M | -2.84M |
| Capital Expenditures | - | -536.84K | -250.00K | - | - |
| Acquisitions | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - |
| Other Investing Acitivies | - | -500 | -250.00K | - | - |
| Investing Cash Flow | - | -536.84K | -250.00K | - | - |
| Debt Repayment | - | - | - | 149.05K | - |
| Common Stock Repurchased | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | - | -102.07K | 4.98M | 1.00M | 1.96M |
| Financial Cash Flow | - | -102.07K | 58.39M | 1.15M | 1.96M |
| Net Cash Flow | -21.05M | -14.19M | 49.34M | 114.43K | -878.69K |
| Free Cash Flow | -21.05M | -14.09M | -9.05M | -1.03M | -2.84M |